annual D&A:
$6.71M+$803.00K(+13.58%)Summary
- As of today (September 16, 2025), KRYS annual depreciation & amortization is $6.71 million, with the most recent change of +$803.00 thousand (+13.58%) on December 31, 2024.
- During the last 3 years, KRYS annual D&A has risen by +$4.87 million (+263.12%).
- KRYS annual D&A is now at all-time high.
Performance
KRYS Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$1.54M-$91.00K(-5.57%)Summary
- As of today (September 16, 2025), KRYS quarterly depreciation & amortization is $1.54 million, with the most recent change of -$91.00 thousand (-5.57%) on June 30, 2025.
- Over the past year, KRYS quarterly D&A has dropped by -$478.00 thousand (-23.65%).
- KRYS quarterly D&A is now -36.71% below its all-time high of $2.44 million, reached on December 31, 2023.
Performance
KRYS quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$6.26M-$478.00K(-7.09%)Summary
- As of today (September 16, 2025), KRYS TTM depreciation & amortization is $6.26 million, with the most recent change of -$478.00 thousand (-7.09%) on June 30, 2025.
- Over the past year, KRYS TTM D&A has dropped by -$633.00 thousand (-9.18%).
- KRYS TTM D&A is now -17.59% below its all-time high of $7.60 million, reached on September 30, 2024.
Performance
KRYS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
KRYS Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.6% | -23.6% | -9.2% |
| 3 y3 years | +263.1% | +58.1% | +76.0% |
| 5 y5 years | +516.0% | +195.0% | +341.2% |
KRYS Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +263.1% | -36.7% | +118.9% | -17.6% | +76.0% |
| 5 y | 5-year | at high | +516.0% | -36.7% | +223.5% | -17.6% | +341.2% |
| alltime | all time | at high | >+9999.0% | -36.7% | >+9999.0% | -17.6% | >+9999.0% |
KRYS Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.54M(-5.6%) | $6.26M(-7.1%) |
| Mar 2025 | - | $1.63M(+5.1%) | $6.74M(+0.4%) |
| Dec 2024 | $6.71M(+13.6%) | $1.55M(+1.7%) | $6.71M(-11.6%) |
| Sep 2024 | - | $1.53M(-24.3%) | $7.60M(+10.2%) |
| Jun 2024 | - | $2.02M(+25.6%) | $6.89M(+16.6%) |
| Mar 2024 | - | $1.61M(-34.0%) | $5.91M(+18.1%) |
| Dec 2023 | $5.91M(+74.6%) | $2.44M(+195.2%) | $5.01M(+36.9%) |
| Sep 2023 | - | $826.00K(-20.4%) | $3.66M(-3.9%) |
| Jun 2023 | - | $1.04M(+47.2%) | $3.81M(+1.7%) |
| Mar 2023 | - | $705.00K(-35.3%) | $3.75M(-7.6%) |
| Dec 2022 | $3.38M(+83.1%) | $1.09M(+11.7%) | $4.05M(+8.1%) |
| Sep 2022 | - | $975.00K(-0.1%) | $3.75M(+5.4%) |
| Jun 2022 | - | $976.00K(-3.8%) | $3.56M(+9.5%) |
| Mar 2022 | - | $1.01M(+29.5%) | $3.25M(+17.3%) |
| Dec 2021 | $1.85M(-0.1%) | $784.00K(+0.1%) | $2.77M(+11.9%) |
| Sep 2021 | - | $783.00K(+17.6%) | $2.48M(+14.1%) |
| Jun 2021 | - | $666.00K(+24.3%) | $2.17M(+7.1%) |
| Mar 2021 | - | $536.00K(+9.4%) | $2.03M(+9.5%) |
| Dec 2020 | $1.85M | $490.00K(+2.7%) | $1.85M(+13.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $477.00K(-8.8%) | $1.64M(+15.4%) |
| Jun 2020 | - | $523.00K(+44.9%) | $1.42M(+24.9%) |
| Mar 2020 | - | $361.00K(+30.8%) | $1.14M(+16.6%) |
| Dec 2019 | $1.09M(+673.0%) | $276.00K(+6.6%) | $974.00K(+28.3%) |
| Sep 2019 | - | $259.00K(+7.9%) | $759.00K(+41.1%) |
| Jun 2019 | - | $240.00K(+20.6%) | $538.00K(+67.1%) |
| Mar 2019 | - | $199.00K(+226.2%) | $322.00K(+128.4%) |
| Dec 2018 | $141.00K(+513.0%) | $61.00K(+60.5%) | $141.00K(+50.0%) |
| Sep 2018 | - | $38.00K(+58.3%) | $94.00K(+54.1%) |
| Jun 2018 | - | $24.00K(+33.3%) | $61.00K(+52.5%) |
| Mar 2018 | - | $18.00K(+28.6%) | $40.00K(+73.9%) |
| Dec 2017 | $23.00K(+1050.0%) | $14.00K(+180.0%) | $23.00K(+130.0%) |
| Sep 2017 | - | $5000.00(+66.7%) | $10.00K(+100.0%) |
| Jun 2017 | - | $3000.00(+200.0%) | $5000.00(+66.7%) |
| Mar 2017 | - | $1000.00(0.0%) | $3000.00(+50.0%) |
| Dec 2016 | $2000.00 | $1000.00(>+9900.0%) | $2000.00(+100.0%) |
| Sep 2016 | - | $0.00(-100.0%) | $1000.00(0.0%) |
| Jun 2016 | - | $1000.00(>+9900.0%) | $1000.00(>+9900.0%) |
| Mar 2016 | - | $0.00 | $0.00 |
FAQ
- What is Krystal Biotech, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. annual D&A year-on-year change?
- What is Krystal Biotech, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. quarterly D&A year-on-year change?
- What is Krystal Biotech, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. TTM D&A year-on-year change?
What is Krystal Biotech, Inc. annual depreciation & amortization?
The current annual D&A of KRYS is $6.71M
What is the all time high annual D&A for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high annual depreciation & amortization is $6.71M
What is Krystal Biotech, Inc. annual D&A year-on-year change?
Over the past year, KRYS annual depreciation & amortization has changed by +$803.00K (+13.58%)
What is Krystal Biotech, Inc. quarterly depreciation & amortization?
The current quarterly D&A of KRYS is $1.54M
What is the all time high quarterly D&A for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high quarterly depreciation & amortization is $2.44M
What is Krystal Biotech, Inc. quarterly D&A year-on-year change?
Over the past year, KRYS quarterly depreciation & amortization has changed by -$478.00K (-23.65%)
What is Krystal Biotech, Inc. TTM depreciation & amortization?
The current TTM D&A of KRYS is $6.26M
What is the all time high TTM D&A for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high TTM depreciation & amortization is $7.60M
What is Krystal Biotech, Inc. TTM D&A year-on-year change?
Over the past year, KRYS TTM depreciation & amortization has changed by -$633.00K (-9.18%)